A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)
Public ClinicalTrials.gov record NCT06169319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-blind, Randomized, Placebo-controlled, Dose-ranging Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fasciitis (PFA)
Study identification
- NCT ID
- NCT06169319
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Endo Pharmaceuticals
- Industry
- Enrollment
- 231 participants
Conditions and interventions
Conditions
Not listed
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2024
- Primary completion
- Sep 29, 2024
- Completion
- Sep 29, 2024
- Last update posted
- Sep 29, 2025
2024
United States locations
- U.S. sites
- 9
- U.S. states
- 2
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Site 8 | Tucson | Arizona | 85712 | — |
| Endo Site 20 | Castro Valley | California | 94546 | — |
| Endo Site 13 | Corona | California | 92882 | — |
| Endo Site 6 | Encinitas | California | 92024 | — |
| Endo Site 11 | Fresno | California | 93710 | — |
| Endo Site 16 | Los Angeles | California | 90010 | — |
| Endo Site 40 | Los Angeles | California | 90063 | — |
| Endo Site 21 | San Francisco | California | 94115 | — |
| Endo Site 10 | Tarzana | California | 91356 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06169319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06169319 live on ClinicalTrials.gov.